Phase II Trial of S-1 Treatment as Palliative-Intent Chemotherapy for Previously Treated Advanced Thymic Carcinoma

被引：0

作者：

Ohyanagi, F. ^{[1
]}

Okuma, Y. ^{[2
]}

Goto, Y. ^{[3
]}

Sunami, K. ^{[4
]}

Nakahara, Y. ^{[2
]}

Kitazono, S. ^{[1
]}

Tambo, Y. ^{[1
]}

Yanagitani, N. ^{[1
]}

Kanda, S. ^{[3
]}

Horiike, A. ^{[1
]}

Horinouchi, H. ^{[3
]}

Fujiwara, Y. ^{[3
]}

Nokihara, H. ^{[3
]}

Yamamoto, N. ^{[3
]}

Nishio, M. ^{[1
]}

Ohe, Y. ^{[3
]}

Hosomi, Y. ^{[2
]}

机构：

[1] Japanese Fdn Canc Res, Dept Thorac Med Oncol, Canc Inst Hosp, Tokyo, Japan

[2] Komagome Hosp, Dept Thorac Oncol & Resp Med, Tokyo Metropolitan Canc & Infect Dis, Tokyo, Japan

[3] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan

[4] Natl Canc Ctr, Dept Pathol & Clin Lab, Tokyo, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期

关键词：

chemotherapy; Thymic carcinoma; S-1;

D O I：

10.1016/j.jtho.2017.09.599

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MA 16.04

引用

页码：S1868 / S1868

页数：1

共 50 条

[1] Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma
Okuma, Y.
Goto, Y.
Ohyanagi, F.
Sunami, K.
Nakahara, Y.
Kitazono, S.
Tambo, Y.
Yanagitani, N.
Kanda, S.
Horinouchi, H.
Horiike, A.
Fujiwara, Y.
Nokihara, H.
Yamamoto, N.
Nishio, M.
Ohe, Y.
Hosomi, Y.
ANNALS OF ONCOLOGY, 2017, 28
[2] Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma
Okuma, Yusuke
Goto, Yasushi
Ohyanagi, Fumiyoshi
Sunami, Kuniko
Nakahara, Yoshiro
Kitazono, Satoru
Kudo, Keita
Tambo, Yuichi
Kanda, Shintaro
Yanagitani, Noriko
Horiike, Atsushi
Horinouchi, Hidehito
Fujiwara, Yutaka
Nokihara, Hiroshi
Yamamoto, Noboru
Nishio, Makoto
Ohe, Yuichiro
Hosomi, Yukio
CANCER MEDICINE, 2020, 9 (20): : 7418 - 7427
[3] Response to Cytotoxic Chemotherapy in Patients Previously Treated With Palliative-Intent Chemotherapy for Advanced Thymic Carcinoma
Okuma, Yusuke
Hosomi, Yukio
Takahashi, Satoshi
Maeda, Yoshiharu
Okamura, Tatsuru
Hishima, Tsunekazu
CLINICAL LUNG CANCER, 2015, 16 (03) : 221 - 227
[4] Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy
Okuma, Yusuke
Ko, Ryo
Shukuya, Takehito
Tateishi, Kazunari
Imai, Hisao
Iwasawa, Shunichiro
Miyauchi, Eisaku
Kojima, Tetsuya
Fujita, Yuka
Hino, Toshihiko
Yamanda, Shinsuke
Suzuki, Toshiro
Fukuizumi, Aya
Sakakibara, Tomohiro
Harada, Toshiyuki
Morita, Satoshi
Kobayashi, Kunihiko
Nukiwa, Toshihiro
Takahashi, Kazuhisa
LUNG CANCER, 2020, 148 : 122 - 128
[5] Phase II trial of amrubicin in patients with previously treated advanced thymic malignancies
不详
JOURNAL OF THORACIC DISEASE, 2015, 7
[6] Osseous oligometastases from thymic carcinoma: a case report suggesting the effectiveness of palliative-intent radiotherapy treatment
Kashima, Jumpei
Horio, Hirotoshi
Okuma, Yusuke
Hosomi, Yukio
Hishima, Tsunekazu
ONCOTARGETS AND THERAPY, 2016, 9 : 1029 - 1032
[7] Crucial role of treatment with palliative intent for a patient with advanced thymic carcinoma
Nagamata, Makoto
Okuma, Yusuke
Yamada, Yuko
Hosomi, Yukio
Hishima, Tsunekazu
ONCOLOGY LETTERS, 2014, 8 (02) : 513 - 516
[8] A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma
Lee, Dae-Won
Lee, Kyung-Hun
Kim, Hee-Jun
Kim, Tae-Yong
Kim, Jin-Soo
Han, Sae-Won
Oh, Do-Youn
Kim, Jee Hyun
Im, Seock-Ah
Kim, Tae-You
BMC CANCER, 2018, 18
[9] A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma
Dae-Won Lee
Kyung-Hun Lee
Hee-Jun Kim
Tae-Yong Kim
Jin-Soo Kim
Sae-Won Han
Do-Youn Oh
Jee Hyun Kim
Seock-Ah Im
Tae-You Kim
BMC Cancer, 18
[10] S-1 MONOTHERAPY FOR ADVANCED THYMIC CARCINOMA
Kato, Yuka
Hotta, Katsuyuki
Tamura, Tomoki
Kayatani, Hiroe
Gotoda, Hiroko
Kudo, Kenichirou
Minami, Daisuke
Sato, Akiko
Ichihara, Eiki
Tabata, Masahiro
Tanimoto, Mitsune
Kiura, Katsuyuki
RESPIROLOGY, 2013, 18 : 142 - 142

← 1 2 3 4 5 →